INSM
Insmed Incorporated Healthcare - Biotechnology Investor Relations →
Insmed Incorporated (INSM) closed at $149.86 as of 2026-02-02, trading 157.0% above its 200-week moving average of $58.31. The stock is currently moving closer to the line, down from 171.9% last week. With a 14-week RSI of 26, INSM is in oversold territory.
Over the past 1292 weeks of data, INSM has crossed below its 200-week moving average 24 times. On average, these episodes lasted 32 weeks. Historically, investors who bought INSM at the start of these episodes saw an average one-year return of +37.5%.
With a market cap of $32.0 billion, INSM is a large-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at -165.7%. The stock trades at 33.7x book value.
Share count has increased 51.1% over three years, indicating dilution.
Over the past 24.8 years, a hypothetical investment of $100 in INSM would have grown to $256, compared to $859 for the S&P 500. INSM has returned 3.9% annualized vs 9.0% for the index, underperforming the broader market over this period.
Free cash flow has been declining. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Growth of $100: INSM vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After INSM Crosses Below the Line?
Across 24 historical episodes, buying INSM when it crossed below its 200-week moving average produced an average return of +36.2% after 12 months (median +20.0%), compared to +13.8% for the S&P 500 over the same periods. 54% of those episodes were profitable after one year. After 24 months, the average return was +62.1% vs +29.1% for the index.
Each line shows $100 invested at the moment INSM crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
INSM has crossed below its 200-week MA 24 times with an average 1-year return of +37.5% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| May 2001 | Dec 2005 | 242 | 93.4% | -43.8% | +270.9% |
| Apr 2006 | Apr 2006 | 1 | 5.9% | -42.2% | +802.8% |
| May 2006 | Apr 2009 | 153 | 68.4% | -53.0% | +802.8% |
| Jun 2009 | Feb 2010 | 33 | 31.8% | -33.3% | +1413.7% |
| May 2010 | Apr 2011 | 47 | 40.1% | +10.4% | +1727.6% |
| Aug 2011 | Nov 2012 | 67 | 65.7% | -15.0% | +3637.2% |
| Nov 2012 | Mar 2013 | 16 | 18.9% | +126.3% | +1993.0% |
| Jan 2016 | Feb 2017 | 58 | 35.1% | +15.7% | +1029.3% |
| Mar 2017 | Mar 2017 | 1 | 1.0% | +37.2% | +847.9% |
| May 2017 | Jun 2017 | 4 | 3.6% | +71.8% | +832.5% |
| Jul 2017 | Sep 2017 | 5 | 28.9% | +84.7% | +958.3% |
| Sep 2018 | Sep 2018 | 1 | 0.3% | -1.5% | +684.6% |
| Oct 2018 | Jan 2019 | 14 | 39.1% | +1.9% | +768.3% |
| Jul 2019 | Nov 2019 | 15 | 18.2% | +50.0% | +760.8% |
| Jan 2020 | Jan 2020 | 1 | 0.7% | +109.1% | +645.9% |
| Mar 2020 | Apr 2020 | 6 | 31.0% | +91.3% | +633.2% |
| May 2021 | Jun 2021 | 3 | 5.2% | -21.7% | +479.7% |
| Jul 2021 | Aug 2021 | 5 | 10.1% | -7.9% | +518.2% |
| Nov 2021 | Dec 2021 | 1 | 0.8% | -21.3% | +478.8% |
| Jan 2022 | Aug 2022 | 30 | 29.8% | -28.2% | +482.0% |
| Aug 2022 | Sep 2023 | 55 | 35.4% | -13.5% | +496.3% |
| Sep 2023 | Nov 2023 | 9 | 7.1% | +187.0% | +493.5% |
| Mar 2024 | Mar 2024 | 1 | 1.3% | +197.6% | +482.7% |
| Apr 2024 | May 2024 | 6 | 15.4% | +198.7% | +516.2% |
| Average | 32 | — | +37.5% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02